Within the framework of the Vietnam-Japan Public-Private Forum on Economic, Scientific and Technological Cooperation, held in Tokyo on November 9 as part of the official visit to Japan by Party General Secretary and President To Lam of Vietnam, the Mescells|MSC Specialized Healthcare System for Regenerative Medicine & Cell Therapy of Vietnam and CM Plus Corporation of Japan signed a Memorandum of Understanding (MOU), under the witness of the top Vietnamese leader and senior leaders of both countries.
The agreement aims to promote professional cooperation, transfer management experience, and standardize cell production facilities (Cell Processing Center – CPC) in Vietnam according to the standards and technical requirements applied in Japan.
According to the agreement, CM Plus Corporation will provide professional consulting services, supporting Mescells|MSC in the process of standardizing and registering the recognition of cell production facilities in Hanoi according to Japanese standards and requirements for the Cell Processing Center (CPC).
The focus of the cooperation is to meet the requirements set by the Ministry of Health, Labor and Welfare of Japan (MHLW), through the establishment of a quality management system (QMS), completion of operational procedures, facility conditions, and technical requirements in cell processing and production activities.
These are crucial factors to ensure that cell production activities are controlled according to professional procedures and quality requirements.
CM Plus Corporation is a Japanese enterprise operating in the field of quality management consulting, regulatory compliance, project management, and construction of production facilities in the life sciences sectors, particularly pharmaceuticals, medical devices, and regenerative medicine.
The company has experience in consulting on quality management systems, GMP/GDP, GCTP standards, GAP assessments, facility validation, and professional training. In the field of regenerative medicine, CM Plus participates in planning, constructing, and standardizing Cell Processing Centers.
In Vietnam, CM Plus established a subsidiary in 2013, implementing consulting, training, and cooperation connection activities.
Through this cooperation, Mescells|MSC aims to access Japanese management experience, quality control, and technical processes, gradually improving the operational capacity of cell production facilities in Hanoi.
Moreover, through collaboration with CM Plus Corporation, Mescells|MSC aims to standardize cell production facilities in Hanoi according to Japanese standards, gradually enhancing quality management capabilities, research, and development of cell technology in the field of regenerative medicine.
Mescells|MSC is a healthcare system operating in the fields of research, training, production, and application of cell technology and regenerative medicine.
Within this system, the Mescells Institute of Applied Cell Technology Research is licensed by the Vietnamese Ministry of Science and Technology to research cell technology and therapies in regenerative medicine. The institute is also licensed by the Department of Science, Technology and Training under the Vietnamese Ministry of Health to train doctors and medical staff in stem cell technology.
Additionally, the Mescells Tissue Bank is licensed by the Ministry of Health to operate with functions of receiving, preserving, storing, and transporting adipose tissue and umbilical cord tissue.
Based on research, training, and tissue storage activities, Mescells|MSC aims to develop cell production facilities according to international standards, gradually completing the chain of activities from research to production and application of cell technology.
Google translate